Scott Waldman
@scott_waldman
ID: 45327052
07-06-2009 11:56:09
19 Tweet
25 Followers
13 Following
A systematic review of datasets that can help elucidate relationships among gene expression, race, and immunohistochemistry-defined subtypes in #breastcancer #PrecisionMedicine tandfonline.com/doi/full/10.10⦠Breast Cancer Breast Cancer Now
Scott Waldman moving the needle forward on GUYC2C re-activation for colon cancer prevention pubmed.ncbi.nlm.nih.gov/34632925/ For an excellent review @adamsnookphd on GUYC2C as a therapeutic target for GI cancers see pubmed.ncbi.nlm.nih.gov/34056991/ #Gastroenterology #CANCER
Find out how NSUN6 regulates GBM response to TMZ independent of MGMT promoter status in the newly published article in Cancer Biology & Therapy by Awah Chidiebere Weill Cornell Medicine #Cancer #cancerresearch NIHBrainTumor Scott Waldman EIC
Great review on the impact of oxygen and metabolic reprogramming on tumor cell metastases #cancer #CancerResearch MVH Lab Lucas Sullivan Scott Waldman EIC
Progress in the fight against #pancreaticcancer. Great review tandfonline.com/doi/full/10.10⦠of the role of multi-D Tx for BRCA mutated metastatic pancreatic cancer OHSU Knight Cancer Institute @sloan_kettering Weill Cornell Medicine #Cancer @adamsnookphd Scott Waldman EIC
Another win for liquid biopsies. k-ras mutant detection for #PancreaticCancer after surgery å²”å±±å¤§å¦ Rolfe Pancreatic Cancer Foundation tandfonline.com/doi/full/10.10⦠Scott Waldman EIC
Dead or alive? An issue in the voting booth as well as with the #TCGA datasets. tandfonline.com/doi/full/10.10⦠#CancerResearch #DataAnalytics #Genomics Scott Waldman EIC
Salvage #sintilimab (PD1 inhibitor) following failed R-CHOP and CAR-T cell therapy for transformed follicular lymphoma tandfonline.com/doi/full/10.10⦠#lymphoma UMGCCC #Immunotherapy Former Account of Eli Lilly and Company Scott Waldman EIC
Great article defining the MOA of metformin as a #chemotherapy sensitizer. tandfonline.com/doi/full/10.10⦠Johns Hopkins Kimmel Cancer Center #CancerResearch Scott Waldman EIC
š¢ Join me in congratulation 2023 Impact awardee Scott Waldman who will be targeting GUCY2C to prevent neurodegeneration in #Parkinsons disease Thomas Jefferson University! Parkinson's Foundation
Love to see my old pal #GUCY2C making waves⦠all thanks to my brilliant wife ā¦Lara Cheslowā© and her A+ team led by Scott Waldman at ā¦Thomas Jefferson Universityā© ! Congrats! nature.com/articles/s4153ā¦
Drs. Lara Cheslow & Scott Waldman at Thomas Jefferson Universityš uncover a novel role for the GUCY2C-cGMP signaling axis in controlling mitochondrial dysfunction and toxicity in substantia nigra pars compacta š§ dopaminergic #neurons. š npj Journals | go.nature.com/44ibNzH
šCongratulations to Impact Awardee Scott Waldman and team for their latest paper, which suggests that guanylyl cyclase C (GUCY2C) signaling is protective against dopamine neuron degeneration. ncbi.nlm.nih.gov/pmc/articles/P⦠#RichardSmeyne Parkinson's Foundation (1/2)
#ResearchWednesday: Scott Waldman has been studying the gut receptor protein GUCY2C in colorectal cancer for years. Now his team has discovered it may protect brain cells in Parkinsonās disease. Curly By Naturee In Stem highlighted the new study: nexus.jefferson.edu/science-and-te⦠#JeffersonResearch